InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Olson Eric R, Directeur Scientifique. Director active across 1 company, notably Syros Pharmaceuticals, Inc.. Cumulatively, 5 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €2k. Activity tracked since 17 July 2023. The latest transaction was filed on 17 July 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Olson Eric R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
689 股@ US$3.504.0% 占其流量Common StockSEC:0001209191-23-042669:0
2,000 股Common StockSEC:0001209191-23-022970:0
27,266 股@ €1.011553.0% 占其流量Common StockSEC:0001209191-22-022503:0
2,208 股@ €3.072513.0% 占其流量Common StockSEC:0001209191-22-002216:0
1,164 股@ €4.68510.5% 占其流量Common StockSEC:0001209191-21-044493:0
5 条申报中的 5 条
About Olson Eric R
Eric R. Olson is the Chief Scientific Officer at Syros Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts. With a strong background in the pharmaceutical field, he plays a key role in innovation and the discovery of new treatments. Syros Pharmaceuticals focuses on developing targeted therapies for genetic diseases and cancer.
